tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
LENZ
LENZ Therapeutics
RESEARCH TOOLSreports
Want to see LENZ full AI Analyst Report?

LENZ Therapeutics (LENZ) Income Statement

384 Followers

LENZ Therapeutics Income Statement

Last quarter (Q4 2025), LENZ Therapeutics's total revenue was $1.59M, an increase of Infinity% from the same quarter last year. In Q4, LENZ Therapeutics's net income was $-35.90M. See LENZ Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 19.09M$ 0.00$ 0.00$ 15.00M$ 0.00
Gross Profit
$ 18.67M$ -58.00K$ 0.00$ 15.00M$ -734.00K
Operating Expenses
$ 109.81M$ 58.55M$ 72.43M$ 25.48M$ 59.71M
Depreciation and Amortization
$ 287.00K$ 58.00K$ 15.00K$ 8.00K$ 734.00K
EBITDA
$ -91.14M$ -49.71M$ -72.41M$ -10.47M$ -70.03M
Operating Income
$ -91.14M$ -58.61M$ -72.43M$ -10.48M$ -60.44M
Other Income/Expenses
$ 9.51M$ 8.84M$ 2.28M$ 19.00K$ -10.32M
Pretax Income
$ -81.63M$ -49.77M$ -70.15M$ -10.46M$ -70.76M
Net Income
$ -82.13M$ -49.77M$ -69.97M$ -10.81M$ -70.76M
Per Share Metrics
Basic EPS
$ -2.85$ -2.34$ -15.30$ -12.89$ -8.54
Diluted EPS
$ -2.85$ -2.34$ -15.30$ -12.89$ -8.54
Weighted Average Shares Outstanding
 28.81M 21.28M 8.15M 7.84M 8.29M
Weighted Average Shares Outstanding (Diluted)
 28.81M 21.28M 8.15M 7.84M 8.29M
Currency in USD

LENZ Therapeutics Earnings and Revenue History